Also I think that article clarified fir me why the "ex vivo" was not a negative, as I had initially thought. Obviously in the field of vaccines or cancer or many other indications, this process of editing cells then replacing them back into the donor certainly has merit.
- Forums
- ASX - By Stock
- Ann: Successful Delivery of CRIPR/Cas9 into Cells ex vivo
PYC
pyc therapeutics limited
Add to My Watchlist
1.59%
!
$1.28

Also I think that article clarified fir me why the "ex vivo" was...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.28 |
Change
0.020(1.59%) |
Mkt cap ! $743.6M |
Open | High | Low | Value | Volume |
$1.26 | $1.28 | $1.24 | $46.67K | 37.07K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 15857 | $1.26 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.30 | 700 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15857 | 1.260 |
1 | 418 | 1.245 |
1 | 25000 | 1.225 |
1 | 10000 | 1.220 |
1 | 850 | 1.200 |
Price($) | Vol. | No. |
---|---|---|
1.300 | 700 | 1 |
1.310 | 7427 | 1 |
1.320 | 10000 | 1 |
1.340 | 9300 | 1 |
1.400 | 18450 | 1 |
Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |